Regeneron Is Down, Not Out

Biotech stock Regeneron should recover from a surprise injunction over a new cholesterol drug.


Vote on this story -->>>

Comments are closed.

this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami